# The Influence of Chronic CMV Infection on Influenza Vaccine Responses

> **NCT02134184** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 78 (actual)

## Conditions studied

- Cytomegalovirus Infections
- Influenza

## Interventions

- **BIOLOGICAL:** Fluzone® 2012-2013 Formula NDC No 498281-012-50

## Key facts

- **NCT ID:** NCT02134184
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2023-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02134184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02134184, "The Influence of Chronic CMV Infection on Influenza Vaccine Responses". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02134184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*